🦊/Investors

Parkwalk AdvisorsFull Portfolio

51 tracked investments · listed companies and verified rows first

52 North52north.healthin

52North Health develops NeutroCheck, a diagnostic tool that identifies neutropenia in chemotherapy patients presenting with fever, enabling risk stratification and reducing unnecessary emergency department visits.

BiotechDigital HealthHealthtechMedical DevicesCambridge, GB

Co-investorsMeridian Health VenturesCambridge Angels groupFuture Planet CapitalCambridge Innovation CapitalMilltrust International Group

8power8power.comin𝕏

8power builds 'Fit & Forget' wireless sensors that provide real-time condition monitoring, data and analytics for industrial machinery such as pumps, motors and gearboxes, allowing clients to track remote asset performance and plan maintenance.

Advanced ManufacturingAI & Machine LearningCleantechEnterprise SoftwareHardwareIoTCambridge, GB

Paul Egan(CEO)inGlen Clark(CFO)in

BoardRichard Green(Chairman)

Co-investorsCambridge Angels group

Accelercommaccelercomm.comSeries B · Apr 2023 · $27M

UK developer of 5G physical layer and channel coding IP for satellite non-terrestrial networks, spun out of the University of Southampton.

Co-investorsBloc VenturesIQ Capital

Adsilicoadsilico.ukFeb 2024

adsilico builds generative AI technology that creates diverse virtual patient populations—digital models of human anatomy, physiology, and pathology—to run in silico trials that assess medical device safety and performance before human testing.

AI & Machine LearningHealthtechMedical Devices

Dr Nishant RavikumarinDr Zeike TaylorinProf Alejandro FrangiSheena Macphersonin

Co-investorsNorthern Gritstone

Albus Healthalbushealth.comin𝕏

Albus Health develops clinically validated monitoring technology that tracks respiratory metrics, heart rate, and cough frequency to support clinical studies.

BiotechDigital HealthHealthtechMedical Devices

Prof Maarten De Vos(Head of R&D)

Co-investorsCreative Destruction Lab (CDL)Meridian Health VenturesUCeed Funds

Aqdotaqdot.comin𝕏Apr 2019

Aqdot is a supramolecular chemistry (chem-tech) company that develops proprietary AqFresh air quality and odour/VOC-elimination technology based on encapsulation.

CleantechDeep TechNew Materials

Dr Jing Zhang(Chief Executive Officer & Co-founder)Dr Roger Coulston(Chief Technical Officer & Co-founder)Hugh Rathbone(Chief Commercial Officer)inAlex Anikeeva(Chief Financial Officer)in

BoardTim Wright(Chairman)

Co-investorsProvidence Investment Company LimitedBusiness Growth Fund

Arkivumarkivum.comin𝕏Series A · Aug 2012 · $2M

Arkivum provides a SaaS platform for long-term data archiving and preservation that ensures data remains secure, accessible, and readable for regulated organizations.

Data & InfrastructureEnterprise SoftwareSaaSReading, GB

Matthew [Last name not provided](CTO and Founder)

Co-investorsOxford

Arviatechnologyarviatechnology.comin𝕏

Arvia Technology provides water treatment solutions for removing organic compounds from wastewater across industrial applications including pharmaceutical manufacturing.

Advanced ManufacturingAgTechCleantechClimate TechEnterprise SoftwareRuncorn, GB

Dr. Nigel Brown(Founder)Dr. Ted Roberts

Azul Opticsazuloptics.comin𝕏

azulOptics develops eye-health screening technologies focused on prevention and early detection of eye disease.

HealthtechMedical DevicesBristol, GB

Shelby Temple(CEO, Co-founder)inMatt Evans(COO, Co-founder)in

Barocalbarocal.comin

Clean alternative to fluid refrigerants using barocaloric effect

Co-investorsWorld Fund

BibliUbibliu.comin𝕏

BibliU is a digital learning platform that partners with publishers to provide students affordable, instant access to course content, and offers institutions workflow automation to reduce administrative burden.

EdTechSaaS

Dave Sherwood(Co-Founder & CEO)in

Co-investorsBrick Capital VenturesGreen Shores CapitalGuinness VenturesOxford Science EnterprisesBeyond VenturesBlackRock+2 more

Bitfountbitfount.comin𝕏Series A · Jul 2025 · $8M

Bitfount provides a federated learning and data science platform that enables organizations to run AI models, conduct analytics, and perform model training on private data without transferring it to third parties.

AI & Machine LearningData & InfrastructureDigital HealthEnterprise SoftwareHealthtechLondon, GB

Co-investorsPace VenturesSpeedinvestAhren Innovation CapitalForesight GroupPortfolio Ventures

Brainomixbrainomix.cominSeries A · Sep 2014 · $2M

Brainomix, a spin-out from the University of Oxford, develops AI-powered imaging biomarkers and software that help physicians interpret medical images to support clinical decisions.

AI & Machine LearningDigital HealthMedical DevicesOxford, GB

Michalis Papadakis(CEO)inAlastair Buchan(Co-founder; Oxford Professor of Stroke Medicine)

Co-investorsModi Ventures

Cambridge GaN Devicescamgandevices.comin𝕏Seed · May 2019

Cambridge GaN Devices is a fabless semiconductor company that develops energy-efficient GaN-based power devices for sustainable electronics.

CleantechDeep TechEnergyHardwareSemiconductorsCambridge, GB

Fabio Necco(CEO)in

Co-investorsCambridge Innovation CapitalEMV CapitalIQ CapitalMartlet CapitalBritish Patient Capital

Ceryx Medicalceryxmedical.comSeed · Apr 2022 · $5M

Ceryx Medical develops medical device technology, presenting a leadership and research team alongside its publications.

BiotechHealthtechMedical Devices

Julian Paton(Founder)inStuart Plant(CEO)inMalcolm Hamer(CTO)inBrenig Preest(CFO)in

BoardChas Taylor(Chairman)in

Co-investorsOutset Ventures

Charco Neurotechcharconeurotech.comin𝕏Nov 2021 · $10M

Charco Neurotech develops the CUE1, a non-invasive device that uses vibratory stimulation to ease movement symptoms and improve quality of life for people with Parkinson's disease.

Digital HealthHardwareHealthtechMedical Devices

Co-investorsAmadeus Capital PartnersCambridge Angels groupNew Wave VenturesUTECCrista Galli Ventures

Congenicacongenica.comSeries B · Feb 2017 · $10M

Congenica provides genomic variant analysis and interpretation software for clinical diagnostic laboratories.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCambridge, GB

Co-investorsCambridge Innovation CapitalQVenturesAmadeus Capital PartnersFuture Planet CapitalIDO InvestmentsLegal & General+1 more

Crypto Quantiquecryptoquantique.comin𝕏Series A · Jul 2022 · $7M

Crypto Quantique designs low-footprint security IP and lifecycle software for system-on-chip (SoC), chiplets, and connected IoT devices, ensuring device identity and integrity are anchored in silicon.

CybersecurityHardwareIoTSemiconductorsLondon, GB

Dr Shahram Mossayebi(CEO & Co-Founder)inDr Patrick Camilleri(Co-Founder)inShahram Mossayebi(CEO)inPatrick Camilleri(Cofounder)in

Co-investorsEntrepreneur FirstKima VenturesAccelerated Digital VenturesADV

Cytoracytora.comin𝕏acquired by Applied Systems

Cytora provides AI-powered risk processing software for commercial insurance carriers and brokers to automate underwriting, claims decisions, and portfolio management.

AI & Machine LearningEnterprise SoftwareInsurTech

Richard Hartley(Co-Founder)inAeneas Wiener(Co-Founder, CTO)in

Co-investorsEQT VenturesCambridge Innovation CapitalClaret Capital Partners

Cytoseekcytoseek.ukinSeed · Mar 2021 · $5M

Hone Bio is a pre-clinical biotech company developing NanoPilot lipid nanoparticle (LNP) targeting technology for extrahepatic drug delivery, engineering LNPs to target specific cell types while blocking off-target liver uptake.

BiotechDeep TechBristol, GB

Ben Carterin

Co-investorsFuture Planet Capital

Echopoint Medicalechopointmedical.comin𝕏Series A · May 2024 · $5M

Echopoint Medical develops cardiac technology focused on coronary physiology for interventional cardiology.

Deep TechHardwareHealthtechMedical DevicesLondon, GB

Antony Odell(CEO & Co-Founder)inMalcolm Finlay(CMO & Co-Founder)inAdrien Desjardins(CSO & Co-Founder)inPriscila Hancock(Executive Officer)Nijs van de Vaart(COO)inPri Hancock(CFO)in

Co-investorsUCL Technology FundQueen Mary University of LondonAlbionVC

Entiaentia.coinSeries A · Dec 2019

Entia develops at-home blood monitoring solutions for healthcare providers and patients.

Digital HealthHealthtechMedical Devices

Dr Toby Basey-Fisher(CEO & Founder)

Co-investorsOxford Technology Management

Legislatelegislate.aiin𝕏Jan 2024 · $3.6M

TextMine automates data extraction from business-critical documents using AI, serving enterprises in financial services, legal, and technology sectors that require high accuracy and security in document processing workflows.

AI & Machine LearningFintechLegalTechSaaSLondon, GB

Charles BrecqueinMary Catherine(Chief Legal Officer)

Co-investorsOxford

Mind Foundrymindfoundry.aiinSeed · Nov 2021 · $13.6M

Mind Foundry develops deployed AI and machine learning systems for high-risk, high-complexity operational domains, including defense applications such as multi-sensor data fusion for battlespace situational awareness and threat-signature analysis.

AI & Machine LearningDeep TechDefense Tech

Stephen Roberts(Co-founder)inMichael Osborne(Co-founder)

Co-investorsOxford Science Enterprises

Mogrify Limitedmogrify.co.ukin𝕏Series A · Oct 2023 · $16M

Mogrify is a biotechnology company developing in vivo cellular reprogramming therapies, using its proprietary MOGRIFY and epiMOGRIFY platforms that apply transcriptomic and epigenetic data to identify transcription factor combinations for converting one cell type into another.

BiotechDeep TechHealthtech

Julian Gough(Co-founder)inOwen Rackham(Co-founder)inJose Polo(Co-founder)inDarrin M. Disley(CEO)in

BoardJane Osbourn(Chair)

Co-investorsAhren Innovation CapitalAstellas Venture Management LLC

Opsydiaopsydia.cominApr 2025

Opsydia develops optical and photonic technologies for precision manufacturing, emerging from research in adaptive optics and laser processing at the University of Oxford.

Advanced ManufacturingAI & Machine LearningDeep TechHardwareNew MaterialsSemiconductorsOxford, GB

Martin Booth(Founder and Director)inPatrick Salter(Founder and Director)inDr. Noel Moore(Chief Technology Officer)

BoardNigel Vaughan(Chairman)

Co-investorsOxford Science EnterprisesForesight GroupOxford University Innovation

Orthox Ltd.orthox.comSeries A · Apr 2016 · $4M

Orthox develops FibroFix, a silk fibroin-based implant technology for repairing damaged knee cartilage in patients at risk of developing osteoarthritis.

BiotechHealthtechMedical Devices

Pathfinder Medicalpathfindermed.cominSeries A · Jan 2022 · $12M

Pathfinder Med develops its patented ePATH catheter guidance platform for endovascular procedures in peripheral interventions and vascular access creation.

HardwareHealthtechMedical DevicesLondon, GB

Dr. Lorenzo Patrone(Chief Medical Officer)

Co-investorsCambridge Angels groupDeepbridge Capital

Pet Medixpetmedix.comSeries B · Sep 2021 · $37MAcquired

Novel antibody-based therapeutics platform for animal health.

Co-investorsCambridge Innovation CapitalCompanion FundDigitalis Ventures

PharmEnablepharmenable.cominMay 2023 · $7.5M

PharmEnable applies AI to small molecule drug discovery, focusing on challenging and data-sparse biological targets that traditional methods struggle to address.

AI & Machine LearningBiotechDeep Tech

Hannah Sore(Founder)in

Co-investorsCambridge Angels groupMartlet CapitalMC Healthcare VenturesDiamond Edge VenturesO2h VenturesWren Capital

Phasecraftphasecraft.ioinSeed · Mar 2019 · $990K

Phasecraft develops quantum computing systems and software by combining quantum information theory, materials science, and engineering to advance practical quantum advantage.

AI & Machine LearningDeep TechQuantum Computing

Prof. Ashley Montanaro(Co-Founder & CEO)inProf. Toby Cubitt(Co-Founder, CTO & CSciO)inProf. John Morton(Co-Founder & Director)in

Co-investorsAlbionVCEpisode1Playground GlobalUCL Technology FundPlural

PhoreMostphoremost.comin𝕏Seed · Sep 2024 · $4M

PhoreMost is a biotechnology company developing small molecule drugs and targeted protein degradation therapeutics for cancers with high unmet clinical need, with a lead program (PMC-001) for primary and metastatic brain cancers in Phase 1/2a clinical evaluation.

BiotechMedical DevicesCambridge, GB

Co-investorsAmadeus Capital PartnersAstellas Venture Management LLCCambridge Angels groupUniversity of Cambridge EnterpriseAmadeus Capital SAO2h Ventures

Proxisenseproxisense.comSeries A · Nov 2023 · $1M

Proxisense develops high-performance sensors for monitoring manufacturing processes and diagnostics, with origins in aerospace and defence applications.

Advanced ManufacturingDeep TechHardwareIoTMedical DevicesOxford, GB

Paul Vickery(Founder and Chairman)Kam Chana(Founder and NED)

Co-investorsFuture Planet CapitalOxford Science Enterprises

Quantum Motionquantummotion.techSeries C · May 2026 · $160M

Quantum Motion develops utility-scale quantum computers using silicon spin-qubit architecture compatible with standard semiconductor manufacturing processes and existing foundry supply chains.

Deep TechQuantum ComputingSemiconductors

Co-investorsBosch VenturesDCVC (Data Collective)Octopus VenturesOxford Science EnterprisesRobert Bosch Venture CapitalSony Ventures Corporation+3 more

Semarion - companysemarion.comin𝕏Seed · Mar 2026 · $4M

Semarion is a University of Cambridge spin-out developing the SemaCyte platform, which converts adherent cells into barcoded, ready-to-use reagents for accelerated drug discovery and cell-based research.

BiotechDeep TechMedical DevicesNew MaterialsSaaSCambridge, GB

Jeroen Verheyen(CEO and Co-Founder)inTarun Vemulkar(Co-founder & CTO)in

Co-investorsThe FSE GroupCambridge Capital GroupFound CapitalStart CodonEMV CapitalMartlet Capital

Yasayasa.cominacquired by Mercedes Benz

YASA develops axial flux electric motors ('eMotors') and control systems for electric vehicles and other electrification applications, using a proprietary Yokeless And Segmented Armature design that reduces motor size and weight while increasing power and torque density.

CleantechHardwareMobility & TransportationOxford, GB

Tim Woolmer(CTO & Founder)in

Co-investors24 HaymarketOxford Science EnterprisesInovia Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

1715 LabsACAL EnergyAnimal DynamicsArviaAudiotelligenceBramble EnergyEnhanc3D GenomicsHynt Labs LimitedIkarovecMirriadMoa TechnologyOxford EndovascularParagrafPredictImmuneTextMine

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.